Xiao Hui Ji
Director/Board Member bij LEGEND BIOTECH CORPORATION
Vermogen: 543 400 $ op 31-03-2024
Actieve functies van Xiao Hui Ji
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LEGEND BIOTECH CORPORATION | Director/Board Member | 01-05-2020 | - |
Independent Dir/Board Member | - | - | |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Chairman | 01-01-2017 | - |
Chief Executive Officer | 01-01-2017 | - | |
Founder | 01-01-2017 | - | |
Director/Board Member | 01-01-2017 | - |
Loopbaan van Xiao Hui Ji
Eerdere bekende functies van Xiao Hui Ji
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 01-01-2017 | 01-05-2020 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01-01-2013 | 01-12-2016 |
The BayHelix Group | Director/Board Member | 01-01-2008 | 01-01-2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Chief Executive Officer | - | 01-01-2012 |
Opleiding van Xiao Hui Ji
The University of Chicago | Masters Business Admin |
The University of Sheffield | Graduate Degree |
China Medical University | Graduate Degree |
Statistieken
Internationaal
China | 5 |
Verenigde Staten | 3 |
Zwitserland | 2 |
Operationeel
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
The BayHelix Group | |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
- Beurs
- Insiders
- Xiao Hui Ji
- Ervaring